Flerie has successfully increased its ownership stake in Nanologica to approximately 43.59% by finalizing its offer, enhancing its position in the growing Life Science sector.

Target Information

Flerie currently holds a total of 38,222,779 shares in Nanologica, representing approximately 43.25% of the company's equity and voting rights. As of July 15, 2025, a total of 293,815 shares have been tendered in the Offer, which corresponds to about 0.33% of Nanologica's shares and voting rights. Consequently, Flerie's total ownership in Nanologica has increased to 38,516,594 shares, amounting to approximately 43.59% of the voting rights in the company.

The disbursement of compensation to shareholders who have accepted the Offer is expected to commence on July 22, 2025. Flerie has not acquired any shares outside of the Offer, which was not subject to any completion or financing conditions. The acceptance period has not been extended, and the Offer is thus concluded. Neither Flerie nor any of its affiliates has undertaken to acquire shares or other financial instruments in Nanologica outside of this Offer.

Industry Overview

The Life Science sector in Sweden has experienced robust growth due to increased public and private investments. The industry is characterized by innovation and technological advancement, leveraging Sweden's strong acad